ACHV

7.24

3.85% -0.29

Handel nachbörslich: 7.33 0.09 +1.24%

Achieve Life Sciences Inc (ACHV)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACHV? Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$7.53

Offen:

$7.62

24-Stunden-Volumen:

1.89M

Relative Volume:

1.25

Marktkapitalisierung:

$745.01M

Einnahmen:

Nettoeinkommen (Verlust:

$-51.99M

KGV:

-6.4904

EPS:

-1.1155

Netto-Cashflow:

$-45.31M

1W Leistung:

-3.98%

1M Leistung:

-14.62%

6M Leistung:

+124.15%

1J Leistung:

+126.96%

1-Tages-Spanne:

$7.05

$7.63

1-Wochen-Bereich:

$7.05

$8.28

52-Wochen-Spanne:

$2.62

$8.64

Achieve Life Sciences Inc Stock (ACHV) Company Profile

Firmenname

Achieve Life Sciences Inc

Sektor

Healthcare (1064)

Branche

Biotechnology (595)

Telefon

425-686-1500

Adresse

22722 29TH DR. SE, SEATTLE, BC

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-11-05

Neueste SEC-Einreichungen

ACHV's Discussions on Twitter

Compare ACHV vs VRTX, MRNA, REGN, ARGX, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ACHV Achieve Life Sciences Inc	7.24	775.88M	0	-51.99M	-45.31M	-1.1155
VRTX Vertex Pharmaceuticals Inc	504.73	133.37B	12.34B	4.34B	3.71B	16.87
MRNA Moderna Inc	190.01	79.40B	2.23B	-3.19B	-1.60B	-8.1462
REGN Regeneron Pharmaceuticals Inc	735.20	81.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.21	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	206.64	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-21	Eingeleitet	Canaccord Genuity	Buy
2025-11-25	Eingeleitet	Citizens JMP	Mkt Outperform
2025-08-21	Eingeleitet	H.C. Wainwright	Buy
2024-11-14	Eingeleitet	Rodman & Renshaw	Buy
2024-09-27	Eingeleitet	Raymond James	Strong Buy
2023-05-10	Bestätigt	Maxim Group	Buy
2021-06-23	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten

Oct 01, 2026

Achieve Life Sciences appoints Benjamin Halladay as chief financial officer By Investing.com - Investing.com Canada

Oct 01, 2026

Achieve Life Sciences names Benjamin Halladay as CFO By Investing.com - Investing.com Nigeria

Oct 01, 2026

Achieve Life Sciences appoints Benjamin Halladay as CFO - TradingView

Oct 01, 2026

Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer - Yahoo Finance

Oct 01, 2026

Sep 30, 2026

Stifel initiates coverage of Achieve Life Sciences with Buy rating, $18 price target - TradingView

Sep 30, 2026

Stifel Initiates Achieve Life Sciences (ACHV) with Buy Rating on Cytisinicline Potential - GuruFocus

Sep 30, 2026

Achieve a new Buy at Stifel on potential of smoking cessation drug cytisinicline - Seeking Alpha

Sep 30, 2026

Achieve Life Sciences (NASDAQ:ACHV) Shares Gap UpStill a Buy? - MarketBeat

Sep 30, 2026

ACHV Initiates Coverage On by Stifel -- Rating Set to Buy, PT $1 - GuruFocus

Sep 30, 2026

Stifel Initiates Achieve Life Sciences at Buy With $18 Price Target - marketscreener.com

Sep 30, 2026

Sep 29, 2026

Operating cash flow per share of Achieve Life Sciences, Inc. – HAN:SP4P - TradingView

Sep 29, 2026

Stifel initiates Achieve Life Sciences stock with buy rating By Investing.com - Investing.com South Africa

Sep 29, 2026

Stifel initiates Achieve Life Sciences stock with buy rating - Investing.com

Sep 29, 2026

Achieve Life Sciences (NASDAQ:ACHV) Share Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat

Sep 29, 2026

Sep 28, 2026

A yearlong quit-smoking and vaping study involved 475 adults. Results will be presented Oct. 20. - Stock Titan

Sep 28, 2026

Sep 24, 2026

Achieve Life Sciences (ACHV) Short Interest & Short Float | Updated Sep 2026 - MarketBeat

Sep 24, 2026

Sep 23, 2026

Achieve Life Sciences: Thesis Intact, Setup Remains Constructive (Rating Downgrade) (ACHV) - Seeking Alpha

Sep 23, 2026

Sep 22, 2026

Achieve Life Sciences: A Funded Manufacturing Reset, Not A Broken Clinical Thesis - Seeking Alpha

Sep 22, 2026

Sep 21, 2026

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat

Sep 21, 2026

Sep 18, 2026

Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageTime to Sell? - MarketBeat

Sep 18, 2026

Sep 17, 2026